Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
EN

ENOV

Market Closed

Enovis Corporation

NYSEHealthcareMedical - Devices
US
7.80K employees
CEO: Damien McDonald
Founded: 2008
$20.69
+$0.00(+NaN%)
Market Cap
1.19B
Beta
1.48
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Enovis trades 52% below a high-confidence fair value of $29.82, with valuation methods indicating wide price variability and some contradictions, notably negative DCF versus high price/sales metrics. Strong liquidity contrasts sharply with zero profitability and efficiency scores, signaling financial strain despite growth potential. Monte Carlo analysis shows negligible downside risk, highlighting asymmetrical upside opportunity amid operational challenges.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore ENOV

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

ENOV in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Medical - Devices

Browse industry stocks →